Primary CNS lymphoma is a rare and aggressive cancer with no FDA-approved treatments specific to the disease. While some ...

A Harvard Medical School–led research team has developed an AI tool that can reliably tell apart two look-alike cancers found in the brain but with different origins, behaviors, and treatments. The ...

A key step towards reducing the burden of central nervous system (CNS) disorders is the identification of disease-specific biomarkers that can help predict, monitor, and guide treatment development.

The National Academies’ Forum on Neuroscience and Nervous Systems Disorders hosted a workshop on September 10, 2024, they brought together diverse perspectives to examine the promising but ...

Neurotoxicants are chemicals capable of inducing adverse side effects in the nervous system during development. Neurotoxicants could be of different types, including industrial chemicals, pesticides, ...

Researchers develop a 3D-printed, RNA-activated implant that silences the PTEN gene to promote nerve regrowth after spinal cord injury.